EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Progress and application of intelligent nanomedicine in urinary system tumors

Yingming Xiao, Lei Zhong, Jinpeng Liu, Li Chen, Yi Wu, Ge Li

Journal of Pharmaceutical Analysis · 2024-12 · 14 (12) · 100964

DOI: 10.1016/j.jpha.2024.100964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-12. Verfasst von Yingming Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hos…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary system tumors include malignancies of the bladder, kidney, and prostate, and present considerable challenges in diagnosis and treatment. The conventional therapeutic approaches against urinary tumors are limited by the lack of targeted drug delivery and significant adverse effects, thereby necessitating novel solutions. Intelligent nanomedicine has emerged as a promising therapeutic alternative for cancer in recent years, and uses nanoscale materials to overcome the inherent biological barriers of tumors, and enhance diagnostic and therapeutic accuracy. In this review, we have explored the recent advances and applications of intelligent nanomedicine for the diagnosis, imaging, and treatment of urinary tumors. The principles of nanomedicine design pertaining to drug encapsulation, targeting and controlled release have been discussed, with emphasis on the strategies for overcoming renal clearance and tumor heterogeneity. Furthermore, the therapeutic applications of intelligent nanomedicine, its advantages over traditional chemotherapy, and the challenges currently facing clinical translation of nanomedicine, such as safety, regulation and scalability, have also been reviewed. Finally, we have assessed the potential of intelligent nanomedicine in the management of urinary system tumors, emphasizing emerging trends such as personalized nanomedicine and combination therapies. This comprehensive review underscores the substantial contributions of nanomedicine to the field of oncology and offers a promising outlook for more effective and precise treatment strategies for urinary system tumors.

Schlagwörter

Stichwörter der Autor:innen

Biological barriersDrug deliveryIntelligent nanomedicineUrinary system tumors

Autor:innen und Institutionen

  • Department of Urology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Che…
  • Emergency Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chen…

Zitieren

APA

Xiao, Y., Zhong, L., Liu, J., Chen, L., Wu, Y., & Li, G. (2024). Progress and application of intelligent nanomedicine in urinary system tumors. Journal of Pharmaceutical Analysis, 14(12), 100964. https://doi.org/10.1016/j.jpha.2024.100964

Vancouver

Xiao Y, Zhong L, Liu J, Chen L, Wu Y, Li G. Progress and application of intelligent nanomedicine in urinary system tumors. Journal of Pharmaceutical Analysis. 2024;14(12):100964. doi:10.1016/j.jpha.2024.100964

BibTeX
@article{Xiao2024,
  author = {Xiao, Yingming and Zhong, Lei and Liu, Jinpeng and Chen, Li and Wu, Yi and Li, Ge},
  title = {Progress and application of intelligent nanomedicine in urinary system tumors},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {100964},
  doi = {10.1016/j.jpha.2024.100964}
}
Kostenlos starten →